Understanding the human body is a team effort. That's where the Yachtel group comes in.

Researchers at Yachtolt have been delving into the secrets of probiotics for 90 years.

Yachtold also partners with nature portfolio to advance gut microbiome science through the global grants for gut health, an investigator-led research program.

To learn more about Yachtol, visit yacolp.co.

com.j.j. That's Y-A-K-U-L-T.co.jp. When it comes to a guide for your gut, count on Yacolt.

If you want to prevent lung cancer deaths, there's an important first step. Catch the disease early. Scientists at Johnson & Johnson are developing tools to improve lung cancer deaths, there's an important first step, catch the disease early. Scientists at

Johnson & Johnson are developing tools to improve lung cancer detection with the hope of doing just

that. And that's where Mark Lloyd Davies' work comes in. He's the global head of strategic

initiatives at Johnson & Johnson, working directly with the lung cancer initiative.

And he's devoted to changing public policy so people who are most likely to develop lung cancer can access the regular screenings they need.

Mark recently sat down with Scientific American Custom Media to talk about ways to reach those vulnerable populations earlier.

We know lung cancer is often lethal because it's detected too late.

So you'd think there would be a big push to offer regular screenings,

especially to smokers.

Unfortunately, that's not the case.

There are few or no policy mechanisms which incentivize health systems to catch lung cancer

as an early stage. Mark says that each year only about 5 to 7% of people who qualify receive

a lung cancer screening. And that's in complete contrast, for other cancers such as cervical

cancer, where you have 80% of patients having

their annual cervical cancer check. Why are lung cancer screening so low if we know they'd

save lives? I've been in many summits, meetings, discussions of leading clinicians,

pulnologists, oncologists, policymakers, patient group advocates. And there isn't necessarily a one

...